Patient-Reported Effectiveness and Safety of Etoricoxib in Osteoarthritis (OA)(0663-113)

Phase 4 Completed 500 enrolled Organon and Co

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to collect disease burden of OA and the effectiveness and patient satisfaction of treatment by Etoricoxib in the normal practice setting.

Timeline

Start: 2007-12
Primary completion: 2008-12
Completion: 2008-12

Publications

Results Lin HY, Cheng TT, Wang JH, Lee CS, Chen MH, Lei V, Lac C, Gammaitoni AR, Smugar SS, Chen WJ. Etoricoxib improves pain, function and quality of life: results of a real-world effectiveness trial. Int J Rheum Dis. 2010 May;13(2):144-50. doi: 10.1111/j.1756-185X.2010.01468.x.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Etoricoxib	Small molecule	60 mg	—

Indications

No indication recorded.